Investment
Features
FeesSafety
Academy
More
Pluang+

Compare McKesson Corporation (MCK) vs Southern Copper Corp (SCCO) Price & Performance

McKesson CorporationTrade
Southern Copper CorpTrade

Price performance (Past 24H)

Key statistics

McKesson Corporation vs Southern Copper Corp — how do they compare? McKesson Corporation trades at $825.74 (market cap $97.35B), while Southern Copper Corp trades at $186.51 (market cap $146.07B). The key difference: Southern Copper Corp is the larger of the two by market cap, and Southern Copper Corp pays the higher dividend (2.28%). Which is the better fit depends on your goals.

MCKSCCO
Market Cap
$97.35B$146.07B
Sector
HealthBasic Materials
52-Week High
$995.69$218.85
52-Week Low
$659.01$90.54
Enterprise Value
$101.98B$148.12B
Dividend Yield
0.39%2.28%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

McKesson Corporation

McKesson Corporation (MCK) trades at $831.60, down 1.16% on the day, with a bullish technical signal and positive earnings momentum after beating estimates for three consecutive quarters. The stock shows strong analyst support with an 80% buy rating and a consensus price target of $932.83, implying potential upside. Revenue growth is robust, reaching $359.05 billion in 2025, though net margins remain thin at 1.18%. Cash flow from operations improved to $6.09 billion in 2025, supporting financial stability.

The outlook for MCK is positive, driven by earnings beats, analyst optimism, and solid cash generation. Key opportunities include growth in specialty pharma and oncology services. Risks involve policy uncertainties, competitive pressures, and execution challenges. The stock's current price near key support at $829 suggests a critical level for near-term direction.

Southern Copper Corp

Southern Copper (SCCO) trades at $175.27, up 1.62% on the day, with a bearish technical signal despite recent earnings beats. The company shows strong fundamentals with revenue growth from $11.4B in 2024 to $13.4B in 2025 and net income rising to $4.3B. Valuation ratios are elevated with a P/E of 29.2 and P/B of 12.2. A recent dividend of $1.00 was declared, payable May 29, 2026, alongside a minor stock split.

Outlook is mixed: robust profitability and copper demand from AI infrastructure support growth, but high valuation and bearish analyst consensus pose risks. The consensus price target is $152.79, below the current price, indicating potential downside. Key risks include commodity price volatility and debt levels, though operational cash flow remains strong at $4.75B in 2025.

Returns comparison

Trailing returns across standard periods

About McKesson Corporation

McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.

Read more on MCK

About Southern Copper Corp

Southern Copper Corp is an integrated producer of copper and other minerals and operates the mining, smelting, and refining facilities in Peru and Mexico. Its production includes copper, molybdenum, zinc, and silver. The company operates through the following segments: Peruvian operations, Mexican open-pit operations, and Mexican underground mining operations. Southern Copper generates the majority of its revenue from the sale of copper and the rest from the sale of non-copper products, such as molybdenum, silver, zinc, lead, and gold. Its geographical segments are The Americas, Europe, and Asia.

Read more on SCCO